The American Journal of Medicine
Volume 122, Issue 7 , Pages 672-678 , July 2009

White/Black Racial Differences in Risk of End-stage Renal Disease and Death

  • Andy I. Choi, MD, MAS

      Affiliations

    • Department of Medicine, San Francisco Veterans Affairs (VA) Medical Center and University of California, San Francisco, Calif
    • Department of Epidemiology and Biostatistics, University of California, San Francisco, Calif
    • Corresponding Author InformationRequests for reprints should be addressed to Andy I. Choi, MD, MAS, San Francisco Veterans Affairs Medical Center, Box 111J, 4150 Clement Street, San Francisco, CA 94121
    • ,
  • Rudolph A. Rodriguez, MD

      Affiliations

    • Department of Medicine, VA Puget Sound Healthcare System and University of Washington, Seattle
    • ,
  • Peter Bacchetti, PhD

      Affiliations

    • Department of Epidemiology and Biostatistics, University of California, San Francisco, Calif
    • ,
  • Daniel Bertenthal, MPH

      Affiliations

    • VA Research Enhancement Award Program, San Francisco VA Medical Center, San Francisco, Calif
    • ,
  • German T. Hernandez, MD

      Affiliations

    • Department of Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center at El Paso
    • ,
  • Ann M. O'Hare, MD, MA

      Affiliations

    • Department of Medicine, VA Puget Sound Healthcare System and University of Washington, Seattle

References 

  1. Levey AS, Atkins R, Coresh J, et al. Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney Int. 2007;72:247–259
  2. Schoolwerth AC, Engelgau MM, Hostetter TH, et al. Chronic kidney disease: a public health problem that needs a public health action plan. Prev Chronic Dis. 2006;3:A57
  3. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137–147
  4. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298:2038–2047
  5. United States Renal Data System. 2006 Annual Data Report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006;
  6. U.S. Census Bureau. United States Census 2000. March 17, 2006 http://www.census.gov/main/www/cen2000.htmlAccessed July 3, 2006
  7. Tarver-Carr ME, Powe NR, Eberhardt MS, et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. J Am Soc Nephrol. 2002;13:2363–2370
  8. Xue JL, Eggers PW, Agodoa LY, et al. Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol. 2007;18:1299–1306
  9. Klag MJ, Whelton PK, Randall BL, et al. End-stage renal disease in African-American and white men (16-year MRFIT findings). JAMA. 1997;277:1293–1298
  10. Healthy People 2010. 2nd edn.. Washington, DC: Department of Health and Human Services; 2000;
  11. Powe NR. Let's get serious about racial and ethnic disparities. J Am Soc Nephrol. 2008;19(7):1271–1275
  12. Ayanian JZ, Cleary PD, Weissman JS, Epstein AM. The effect of patients' preferences on racial differences in access to renal transplantation. N Engl J Med. 1999;341:1661–1669
  13. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137:479–486
  14. Powe NR. Let's get serious about racial and ethnic disparities. J Am Soc Nephrol. 2008;19:1271–1275
  15. Ashton CM, Souchek J, Petersen NJ, et al. Hospital use and survival among Veterans Affairs beneficiaries. N Engl J Med. 2003;349:1637–1646
  16. O'Hare AM, Bertenthal D, Covinsky KE, et al. Mortality risk stratification in chronic kidney disease: one size for all ages?. J Am Soc Nephrol. 2006;17:846–853
  17. Choi AI, Rodriguez RA, Bacchetti P, et al. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol. 2007;18:2968–2974
  18. Maynard C, Chapko MK. Data resources in the Department of Veterans Affairs. Diabetes Care. 2004;27(Suppl 2):B22–B26
  19. Backus L, Mole L, Chang S, Deyton L. The Immunology Case Registry. J Clin Epidemiol. 2001;54(Suppl 1):S12–S15
  20. Cowper DC, Kubal JD, Maynard C, Hynes DM. A primer and comparative review of major US mortality databases. Ann Epidemiol. 2002;12(7):462–468
  21. Fisher SG, Weber L, Goldberg J, Davis F. Mortality ascertainment in the veteran population: alternatives to the National Death Index. Am J Epidemiol. 1995;141(3):242–250
  22. Page WF, Mahan CM, Kang HK. Vital status ascertainment through the files of the Department of Veterans Affairs and the Social Security Administration. Ann Epidemiol. 1996;6:102–109
  23. United States Renal Data System. USRDS website http://www.usrds.orgAccessed July 28, 2006
  24. Sohn MW, Zhang H, Arnold N, et al. Transition to the new race/ethnicity data collection standards in the Department of Veterans Affairs. Popul Health Metr. 2006;4:7
  25. Arday SL, Arday DR, Monroe S, Zhang J. HCFA's racial and ethnic data: current accuracy and recent improvements. Health Care Financ Rev. 2000;21:107–116
  26. Borzecki AM, Wong AT, Hickey EC, et al. Identifying hypertension-related comorbidities from administrative data: what's the optimal approach?. Am J Med Qual. 2004;19:201–206
  27. Diez Roux AV, Merkin SS, Arnett D, et al. Neighborhood of residence and incidence of coronary heart disease. N Engl J Med. 2001;345:99–106
  28. Brown WW, Peters RM, Ohmit SE, et al. Early detection of kidney disease in community settings: the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis. 2003;42:22–35
  29. Newsome BB, McClellan WM, Coffey CS, et al. Survival advantage of black patients with kidney disease after acute myocardial infarction. Clin J Am Soc Nephrol. 2006;1:993–999
  30. Hunsicker LG, Adler S, Caggiula A, et al. Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int. 1997;51:1908–1919
  31. Hsu CY, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003;14:2902–2907
  32. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307–1315
  33. Mehrotra R, Kermah D, Fried L, et al. Racial differences in mortality among those with CKD. J Am Soc Nephrol. 2008;19:1403–1410
  34. McClellan W, Warnock DG, McClure L, et al. Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol. 2006;17:1710–1715
  35. Ishani A, Grandits GA, Grimm RH, et al. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial. J Am Soc Nephrol. 2006;17:1444–1452
  36. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med. 1982;306:1276–1279
  37. Heisler M, Smith DM, Hayward RA, et al. Racial disparities in diabetes care processes, outcomes, and treatment intensity. Med Care. 2003;41:1221–1232
  38. Rehman SU, Hutchison FN, Hendrix K, et al. Ethnic differences in blood pressure control among men at Veterans Affairs clinics and other health care sites. Arch Intern Med. 2005;165:1041–1047
  39. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199–206
  40. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305

 Funding: This study was supported by a fellowship grant from the National Kidney Foundation, grants from the National Institutes of Health (K23DK080645-01A1, K23AG028980-03, R01AI069952-03), W.K. Kellogg Scholars in Health Disparities Program, Paso del Norte Health Foundation's Center for Border Health Research, and the San Francisco VA Research Enhancement Award Program to Improve Care for Older Veterans. These funding sources had no involvement in the design or execution of this study.

 Conflict of Interest: GTH has received research support from the Catholic Healthcare West, Genentech, Biogen, Novartis, Roche, and the National Institute of Diabetes and Digestive and Kidney Diseases; he has received honoraria from the National Institute of Environmental Health Sciences and Novartis. AMO receives royalties from UpToDate and research funding from the Centers for Disease Control. These funding sources played no role in the research presented here. The other authors declare no potential financial conflicts of interest.

 Authorship: AIC, AMO, and DB had access to the data; all authors had a role in writing the manuscript.

PII: S0002-9343(08)01258-8

doi: 10.1016/j.amjmed.2008.11.021

The American Journal of Medicine
Volume 122, Issue 7 , Pages 672-678 , July 2009

Article Tools

* Image Usage & Resolution